Coincidentally, I have a friend who is in the second cycle of this IVF procedure to select an embryo that does not carry the genes associated with polycystic kidney disease (PKD). When I heard it last week for the first time, I thought it is already an established procedure. Here, I'm learning that it is a relatively cutting-edge approach and I am now looking forward to asking my friend more about this next time we meet.
Commercial products in the space have been around for several years but can only screen for a small number of genetic diseases at a time. For example, Natera's Spectrum screens for chromosomal abnormalities (eg Down Syndrome) plus one custom genetic problem for a single condition of greatest concern. https://www.natera.com/womens-health/spectrum-preimplantatio...
Some polygenic screening services that look at a much larger number of conditions are just reaching market now (eg Orchid Health), though our ability to map genes correlated with polygenic traits to phenotype results is still in its early stages. https://www.orchidhealth.com/
